BEIJING, March 7 (Xinhua) -- Over one third of China's major development targets for the 2026-2030 period will focus on resolving the pressing difficulties and problems that concern the people most, a ...
BEIJING, March 7 (Xinhua) -- Over one third of China's major development targets for the 2026-2030 period will focus on resolving the pressing difficulties and problems that concern the people most, ...
国家药品监督管理局药品审评中心数据显示，2026年3月5日，Janssen Research & Development, LLC的Pasritamig注射液申请已获受理，受理号为JXSL2600068。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系biz@staff ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果